ARRIVENT BIOPHARMA INC

Ticker: AVBP CUSIP: 04272N102 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 753,519 Value ($000) $15,164 Avg Close $20.82 Range $17.00 - $25.82

Q3 2025

Shares 716,288 Value ($000) $13,218 Avg Close $19.65 Range $16.10 - $23.38

Q2 2025

Shares 596,018 Value ($000) $12,978 Avg Close $20.76 Range $15.47 - $25.80

Q1 2025

Shares 614,523 Value ($000) $11,365 Avg Close $24.47 Range $17.84 - $29.71

Q4 2024

Shares 596,182 Value ($000) $15,886 Avg Close $28.71 Range $23.00 - $36.37

Q3 2024

Shares 597,165 Value ($000) $14,036 Avg Close $22.70 Range $17.21 - $30.99

Q2 2024

Shares 234,944 Value ($000) $4,359 Avg Close $17.83 Range $14.35 - $21.00

Q1 2024

Shares 225,049 Value ($000) $4,020 Avg Close $20.17 Range $16.90 - $25.95

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	753,519	$15,164	$20.82	$17.00 - $25.82
Q3 2025	716,288	$13,218	$19.65	$16.10 - $23.38
Q2 2025	596,018	$12,978	$20.76	$15.47 - $25.80
Q1 2025	614,523	$11,365	$24.47	$17.84 - $29.71
Q4 2024	596,182	$15,886	$28.71	$23.00 - $36.37
Q3 2024	597,165	$14,036	$22.70	$17.21 - $30.99
Q2 2024	234,944	$4,359	$17.83	$14.35 - $21.00
Q1 2024	225,049	$4,020	$20.17	$16.90 - $25.95